Incerti Carlo
SEC insider (Form 3/4/5 filer). CIK 0001915358. Director at Dyne Therapeutics, Inc. (DYN). 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 5, 2026. Located in WALTHAM, MA.
Companies Incerti Carlo has filed insider reports for
- Dyne Therapeutics, Inc. (DYN): Director
Incerti Carlo
CIK: 0001915358
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (25.0%)
Position reduction
Option Exercises (M)1 (25.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
DYN
Dyne Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 5, 2026DYN
Dyne Therapeutics, Inc.
AwardDirectStock option (right to buy)
35.2K shares- - May 30, 2025DYN
Dyne Therapeutics, Inc.
AwardDirectStock option (right to buy)
35K shares- - Nov 18, 2024DYN
Dyne Therapeutics, Inc.
ExerciseDirect16.5K shares at avg. $8.69$143K - Nov 18, 2024DYN
Dyne Therapeutics, Inc.
SaleDirect16.5K shares at avg. $28.73$474K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 5, 2026 | DYN Dyne Therapeutics, Inc. | Award Stock option (right to buy) | 35,152 | - | - | Direct |
| May 30, 2025 | DYN Dyne Therapeutics, Inc. | Award Stock option (right to buy) | 35,000 | - | - | Direct |
| Nov 18, 2024 | DYN Dyne Therapeutics, Inc. | Exercise | 16,500 | $8.69 | $143,385 | Direct |
| Nov 18, 2024 | DYN Dyne Therapeutics, Inc. | Sale | 16,500 | $28.73 | $474,045 | Direct |
1-4 of 4 transactions